CHINA PHARMA HOLDINGS, INC. Accounts Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accounts Payable of $5.85 million as of 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2012-05-14
- 2012-03-31: Accounts Payable, Current $5.85M.
- 2011-12-31: Accounts Payable, Current $3.11M.
- 2011-09-30: Accounts Payable, Current $3.12M.
- 2011-06-30: Accounts Payable, Current $2.77M.
| Period end | Accounts Payable, Current |
|---|---|
| 2012-03-31 | $5.85M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.11M 10-Q · filed 2012-05-14 |
| 2011-09-30 | $3.12M 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $2.77M 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $4.94M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |